Publications by authors named "Judith Kramer"

Claim this Profile
P
Patients with Rheumatic Diseases do not have an Increased Risk of MRSA Carrier Status.
Judith Krämer, Konstantinos Triantafyllias, Wolfgang Kohnen, Martin Leber, Ute Dederichs-Masius

Rheumatol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of left ventricular filling parameters on outcome of patients undergoing trans-catheter aortic valve replacement.
Judith Kramer, Simon Biner, Michael Ghermezi, Gregg S Pressman, Hezzi Shmueli

Eur Heart J Cardiovasc Imaging· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations.
Janet Wittes, Brenda Crowe, Christy Chuang-Stein, Achim Guettner, David Hall, Judith Kramer

Stat Biopharm Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industry Practices for Expedited Reporting to Investigators Conducting Research Under an IND.
Sundeep S Sethi, Judith M Kramer, Suzanne Gagnon, Greg Nadzan, José M Vega

Ther Innov Regul Sci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigators' Experience With Expedited Safety Reports Prior to the FDA's Final IND Safety Reporting Rule.
Judith M Kramer, David Vock, Howard E Greenberg, Cheri Janning, Lynda Szczech

Ther Innov Regul Sci· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application.
Patrick Archdeacon, Cheryl Grandinetti, José M Vega, David Balderson, Judith M Kramer

Ther Innov Regul Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.gov.
Karen P Alexander, David F Kong, Aijing Z Starr, Judith Kramer, Karen Chiswell

J Am Heart Assoc· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participants' perspectives on safety monitoring in clinical trials.
Kathryn E Flynn, Judith M Kramer, Carrie B Dombeck, Kevin P Weinfurt

Clin Trials· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
Devon K Check, Kevin P Weinfurt, Carrie B Dombeck, Judith M Kramer, Kathryn E Flynn

Clin Trials· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using central IRBs for multicenter clinical trials in the United States.
Kathryn E Flynn, Cynthia L Hahn, Judith M Kramer, Devon K Check, Carrie B Dombeck

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
Priscilla Velentgas, Anthony A Amato, Rhonda L Bohn, K Arnold Chan, Thomas Cochrane, Judith M Kramer

Pharmacoepidemiol Drug Saf· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Robert M Califf, Deborah A Zarin, Judith M Kramer, Rachel E Sherman, Laura H Aberle

JAMA· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial.
Sara Bristol Calvert, Judith M Kramer, Kevin J Anstrom, Lisa A Kaltenbach, Judith A Stafford

Am Heart J· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the quality of conduct of clinical trials: a survey of current practices.
Briggs W Morrison, Chrissy J Cochran, Jennifer Giangrande White, Joan Harley, Cynthia F Kleppinger, Judith M Kramer

Clin Trials· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.
Bryan R Luce, Judith M Kramer, Steven N Goodman, Jason T Connor, Sean Tunis

Ann Intern Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
Nancy M Allen LaPointe, Yi Zhou, Judith A Stafford, Adrian F Hernandez, Judith M Kramer

Am J Cardiol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.
Judith M Kramer

N Engl J Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific evidence underlying the ACC/AHA clinical practice guidelines.
Pierluigi Tricoci, Joseph M Allen, Judith M Kramer, Robert M Califf, Sidney C Smith

JAMA· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.
Priscilla Velentgas, Rhonda L Bohn, Jeffrey S Brown, K Arnold Chan, Patricia Gladowski, Judith M Kramer

Pharmacoepidemiol Drug Saf· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of beta-blockers in elderly patients with heart failure.
Judith M Kramer, Lesley H Curtis, Carla S Dupree, David Pelter, Adrian Hernandez

Arch Intern Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and long-term outcomes of heart failure in elderly persons, 2001-2005.
Lesley H Curtis, Melissa A Greiner, Bradley G Hammill, Judith M Kramer, David J Whellan

Arch Intern Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.
Robert M Califf, Judith M Kramer

Pharmacoepidemiol Drug Saf· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postmarket evaluation of breakthrough technologies.
Sunil V Rao, Robert M Califf, Judith M Kramer, Eric D Peterson, Thomas P Gross

Am Heart J· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical outcomes following coronary stenting.
Kevin J Anstrom, David F Kong, Linda K Shaw, Robert M Califf, Judith M Kramer

Arch Intern Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.
David H Smith, Judith M Kramer, Nancy Perrin, Richard Platt, Douglas W Roblin

Arch Intern Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis